Candelanza, Cristine M.
HRN: 14-01-79 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2025
MUPIROCIN 2%, 15G (TUBE)
09/20/2025
09/27/2025
TOPICAL
Apply On Affected Area
BID
SP Pelvic Lap
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes